El-Khoueiry AB, Melero I, Crocenzi TS, et al. Phase I/II safety and antitumor activity of nivolumab in patients with advanced hepatocellular carcinoma (HCC): CA209-040 [abstract]. J Clin Oncol 2015 ; 33 Suppl : LBA101.
Sangro B, Park JW, Dela Cruz CM, et al. A randomized, multicenter, phase 3 study of nivolumab vs sorafenib as first-line treatment in patients (pts) with advanced hepatocellular carcinoma (HCC): CheckMate-459 [abstract]. J Clin Oncol 2016 ; 34 Suppl : TPS4147.
Bang YJ, Doi T, De Braud F, et al. Safety and efficacy of pembrolizumab (MK-3475) in patients (pts) with advanced biliary tract cancer : Interim results of KEYNOTE-028 [abstract 525]. Eur J Cancer 2015 ; 51 Suppl : S112.